Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

Click for more information

3.37%

$14.07 neuren pharmaceuticals limited

I missed the webinar. Why is the PWS trial being canceled?

First 125 Last

Share
Profile

Follow
Jimbo1992

192 Posts.

27

27/05/24

21:12

Post #: 74033541
Share
Originally posted by DumbPostAvenger: ↑

You say of JP:
"I don't think he could tell a fib if he tried and his genuineness is so compelling"

You then go on to contradict that statement:
"the feeling I get is that they are under pressure doing all these trials (despite him saying they could do Phase 3 trials - I don't think it is realistic"

JP was very clear on why they are cancelling the current PWS trial. He was also clear that they wanted to run it again with more favourable protocols.
He was also crystal clear that Neuren could afford to run 2 Ph3 trials.
And as for the pressure they are under, "doing all these trials", they're literally working tirelessly with the aim of doing a whole lot more trials.

I take JP at face value.

Like you, I think JP mentioning Reata was an eye opener, and I do think, if and when a TO comes, this will be the benchmark. But, in the Reata context, JP mentioned that Reata's value was for an FDA approved drug for 1 indication.

So my takeaway is that I agree with Nashezz that a TO this year is not a certainty.
FWIW, Goldenchook, on the Neuren Media and Analysts thread, posted what I think was the most thoughtful post on here in ages.

Expand

I missed the webinar. Why is the PWS trial being canceled?
NEU Price at posting: $23.97 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 36 more messages in this thread...

First 125 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.07		Change -0.490(3.37%)		Mkt cap ! $1.806B

Open	High	Low	Value	Volume
$14.38	$14.42	$14.03	$3.248M	228.6K

Buyers (Bids)

No.	Vol.	Price($)
1	592	$14.05

Sellers (Offers)

Price($)	Vol.	No.
$14.07	803	9

View Market Depth

No.	Vol.	Price($)
3	191	14.060
5	1325	14.050
8	1566	14.040
4	2724	14.030
4	889	14.020

Price($)	Vol.	No.
14.080	731	12
14.090	645	5
14.100	726	7
14.110	1400	8
14.120	1143	4

Last trade - 14.40pm 04/10/2024 (20 minute delay)

NEU (ASX) Chart